Neko Health
Reviewed active Updated Jul 15, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Investors
Founders
About
Neko Health is a Swedish preventive-health company that operates a proprietary full-body scanning platform combining medical imaging, sensor data, and blood analysis with in-clinic physician review 12. It was founded in Stockholm in February 2023 by Spotify co-founder Daniel Ek and Hjalmar Nilsonne, who serves as CEO 123. The company runs clinics in Sweden and the UK — including multiple London locations, Manchester, and Birmingham — and reports that more than 100,000 members have completed a scan and more than 350,000 have registered on the waitlist 12.
On 2026-07-15 Neko Health announced a $700 million Series C at a valuation of approximately $7 billion — a roughly fourfold jump from its January 2025 Series B 123. The round was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners, with participation from existing investors Atomico, General Catalyst, and Lakestar and new investors Liberty City Ventures, Positive Sum, and BDT & MSD 123. Individual investors in the round include Mark Zuckerberg and Priscilla Chan, Tim Ferriss, Maria Sharapova, and will.i.am 12. The company plans to use the capital to open its first US clinics — starting in New York — and to expand research and technology investment in preventive care 123.
Disclaimer: This is a lean profile built from initial round coverage and may be expanded as more information becomes available.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2025-01 | Series B | ~$85M (at ~$1.7B valuation) | — | Atomico, General Catalyst, Lakestar 23 |
| 2026-07-15 | Series C | $700M | Lightspeed Venture Partners (co-lead), O.G. Venture Partners (co-lead) | Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum, BDT & MSD, Mark Zuckerberg, Priscilla Chan, Tim Ferriss, Maria Sharapova, will.i.am 123 |
The Series C values Neko Health at approximately $7 billion 123.
What Investors Say
“We believe this is one of the most important healthcare companies of our generation, and we’re proud to deepen our partnership as they continue to reimagine prevention.” — Bejul Somaia, Partner, Lightspeed Venture Partners, quoted in Tech.eu coverage of the Series C, July 15, 2026 2
What Founders Say
“With this round, we’re taking our mission to the US for the first time, while continuing to invest in research and technology that make prevention possible at scale.” — Hjalmar Nilsonne, Co-Founder & CEO, Neko Health, quoted in Tech.eu coverage of the Series C, July 15, 2026 2
Sources
-
“Daniel Ek’s Neko Health Secures $700M to Fund U.S. Preventive Clinic Expansion,” HIT Consultant, July 15, 2026. Accessed July 15, 2026. https://hitconsultant.net/2026/07/15/neko-health-raises-700-million-series-c/↩↩↩↩↩↩↩↩↩
-
“Neko Health raises $700M as demand grows for preventive health scans,” Tech.eu, July 15, 2026. Accessed July 15, 2026. https://tech.eu/2026/07/15/neko-health-raises-700m-as-demand-grows-for-preventive-health-scans/↩↩↩↩↩↩↩↩↩↩↩↩
-
“Mark Zuckerberg backs Daniel Ek’s health tech startup in $700M funding round ahead of US launch,” Tech Funding News, July 15, 2026. Accessed July 15, 2026. https://techfundingnews.com/neko-health-700m-series-c-daniel-ek-body-scans/↩↩↩↩↩↩↩